Prm219 - A Novel Measure of Drug Benefit-Risk Assessment Based on Scale Loss Score (Slos)

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2337
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Risk‐Benefit Assessment of Foods

EFSA Journal
VeterinaryMicrobiologyFood ScienceAnimal ScienceParasitologyPlant ScienceZoology
2019English

An Assessment of GCM Performance at a Regional Scale Using a Score-Based Method

Advances in Meteorology
Atmospheric ScienceGeophysicsPollution
2018English

Risk Benefit Assessment of Ethinylestradiol Using a Physiologically-Based Pharmacokinetic (PBPK) Modelling Approach

Clinical Pharmacology and Therapeutics
Pharmacology
2018English

On the Consistency of the Z-Score to Measure the Bank Risk

SSRN Electronic Journal
2016English

A Novel Quantitative Measure of Breast Curvature Based on Catenary

IEEE Transactions on Biomedical Engineering
Biomedical Engineering
2012English

Quantifying Preferences in Drug Benefit‐Risk Decisions

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Benefit–risk Assessment of Vitamin D Supplementation

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2009English

A Novel Measure of Treatment Benefit for an Ordinal Scale: A Case Study of the IST-1 and the IST-3 Stroke Trials

Trials
MedicinePharmacology
2013English

Psychometric Assessment of a Scale to Measure Bonding Workplace Social Capital

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy